Dr. Baldeep Singh Pabla, MD, MSCI is a hepatologist in Nashville, TN specializing in hepatology (liver disease) and adult gastroenterology. He graduated from Vanderbilt University School of Medicine in 2013 and has 11 years of experience. Dr. Baldeep Singh Pabla, MD, MSCI is affiliated with Vanderbilt Health and Vanderbilt University Medical Center (VUMC).
3601 The Vanderbilt Clinic
Nashville, TN 37232
719 Thompson Lane Suite 20500
Nashville, TN 37204
Volume of procedures performed by Dr. Baldeep Singh Pabla, MD, MSCI for Medicare patients.
The highest averages for the top procedures that Dr. Baldeep Singh Pabla, MD, MSCI treated as a hepatologist in Nashville, TN were minimally invasive procedures, removal of lesion (e.g. growth), diagnostic procedures and gastrointestinal procedures.
| 149 | |
| 104 | |
| 149 | |
| 46 | |
| 46 | |
| 149 | |
| 149 |
Information about Medicare patients treated by Dr. Baldeep Singh Pabla, MD, MSCI.
| 6 | |
| 7 |
| 8 | |
| 2 | |
| 7 |
The highest averages of the most common conditions of Medicare patients that Dr. Baldeep Singh Pabla, MD, MSCI treated were high cholesterol, hypertension, chronic kidney disease and ischemic heart disease.
| 11 | |
| 12 | |
| 7 | |
| 3 | |
| 8 | |
| 3 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 |
Dr. Baldeep Singh Pabla, MD, MSCI graduated from Vanderbilt University School of Medicine in 2013. He has a state license in Illinois.
Medical School: Vanderbilt University School of Medicine (2013)
Licensed In: Illinois
Dr. Baldeep Singh Pabla, MD, MSCI is associated with these hospitals and organizations:
Dr. Baldeep Singh Pabla, MD, MSCI has an exceptional overall rating with an average of 4.9 out of 5 stars based on 1 ratings. We collect ratings and reviews of Dr. Baldeep Singh Pabla, MD, MSCI from all over the web to help you find the right in Nashville, TN.
These charts describe general payments received by Dr. Baldeep Singh Pabla, MD, MSCI. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$6,680
Tremfya $6,276 |
STELARA $405 |
|||||
|
$4,122
ZEPOSIA $3 |
$4,119 |
|||||
|
$3,339
XELJANZ $3,236 |
$104 |
|||||
|
$1,312
Rinvoq $1,043 |
Skyrizi $243 |
Humira $25 |
||||
|
$294
ZEPOSIA $174 |
$120 |
|||||
|
$802
STELARA $201 |
Biliary Devices $123 |
Humira $123 |
ENTYVIO $91 |
EVIS EXERA $39 |
Other $225 |
| $8,425 | |
| $3,000 | |
| $2,945 | |
| $2,020 | |
| $90 | |
| $70 |
Dr. Baldeep Singh Pabla, MD, MSCI has received 205 research payments totaling $867,516.
Dr. Baldeep Pabla, who practices in Nashville, TN, is a medical specialist in adult gastroenterology and hepatology (liver disease). Areas of particular interest for Dr. Pabla include inflammatory bowel disease. He is a graduate of Vanderbilt University School of Medicine. Dr. Pabla is affiliated with Vanderbilt University Medical Center (VUMC).
